These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 19244147

  • 1. Probiotics and diverticular disease.
    Sheth A, Floch M.
    Nutr Clin Pract; 2009; 24(1):41-4. PubMed ID: 19244147
    [Abstract] [Full Text] [Related]

  • 2. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM.
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [Abstract] [Full Text] [Related]

  • 3. Role of probiotics in management of diverticular disease.
    Narula N, Marshall JK.
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1827-30. PubMed ID: 21091992
    [Abstract] [Full Text] [Related]

  • 4. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM, Kim R.
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [Abstract] [Full Text] [Related]

  • 5. Clinical use of probiotics in the pediatric population.
    Wallace B.
    Nutr Clin Pract; 2009 Nov; 24(1):50-9. PubMed ID: 19244149
    [Abstract] [Full Text] [Related]

  • 6. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC, Sanderson JD, Whelan K.
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M.
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [Abstract] [Full Text] [Related]

  • 9. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM, Flourie B.
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [Abstract] [Full Text] [Related]

  • 10. Inflammation and microflora.
    Pimentel M, Chang C.
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [Abstract] [Full Text] [Related]

  • 11. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 12. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K, Quigley EM.
    Curr Opin Gastroenterol; 2013 Mar 01; 29(2):184-9. PubMed ID: 23286925
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC, Brostoff J, Whelan K, Sanderson JD.
    Am J Gastroenterol; 2008 Jun 01; 103(6):1557-67. PubMed ID: 18513268
    [Abstract] [Full Text] [Related]

  • 14. Probiotics in gastrointestinal disorders.
    Quigley EM.
    Hosp Pract (1995); 2010 Nov 01; 38(4):122-9. PubMed ID: 21068536
    [Abstract] [Full Text] [Related]

  • 15. A hypothesis: important role for gut microbiota in the etiopathogenesis of diverticular disease.
    Daniels L, Philipszoon LE, Boermeester MA.
    Dis Colon Rectum; 2014 Apr 01; 57(4):539-43. PubMed ID: 24608313
    [No Abstract] [Full Text] [Related]

  • 16. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL, Modi R, Cohen E, Spiegel BM.
    Am J Gastroenterol; 2012 Oct 01; 107(10):1486-93. PubMed ID: 22777341
    [Abstract] [Full Text] [Related]

  • 17. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N, Maamouri N, Ouerghi H, Ben Ammar A.
    Tunis Med; 2005 Mar 01; 83(3):132-6. PubMed ID: 15929439
    [Abstract] [Full Text] [Related]

  • 18. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA.
    Aliment Pharmacol Ther; 2006 Oct 01; 24 Suppl 3():90-5. PubMed ID: 16961752
    [Abstract] [Full Text] [Related]

  • 19. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L, Elia C, Navino M, Cisarò F, ARMONIA Study Group.
    Acta Biomed; 2007 Aug 01; 78(2):111-6. PubMed ID: 17933278
    [Abstract] [Full Text] [Related]

  • 20. Is there a role for probiotics in irritable bowel syndrome?
    Camilleri M.
    Dig Liver Dis; 2006 Dec 01; 38 Suppl 2():S266-9. PubMed ID: 17259088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.